| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +50.00% | +2.89% | +2.80% | +0.08% | +0.08% | — |
| 14d | 2 | +50.00% | +5.28% | +2.75% | +2.53% | +2.53% | — |
| 30d | 2 | +50.00% | -0.88% | +4.71% | -5.59% | -5.59% | — |
| 60d | 2 | +50.00% | -16.58% | +2.75% | -19.33% | -19.33% | — |
| 90d | 2 | +50.00% | -10.07% | -0.87% | -9.20% | -9.20% | — |
| 180d | 2 | +50.00% | +5.56% | +2.20% | +3.36% | +3.36% | — |
| 1y | 2 | +50.00% | -4.77% | +7.55% | -12.32% | -12.32% | — |
| 2y | 2 | +50.00% | +14.24% | +23.99% | -9.75% | -9.75% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ABUS ARBUTUS BIOPHARMA CORP | SALE10b5-1 10b5-1 plan | 9,982 | $2.31 | $23.1K | 1,485,121 | Feb 2, 2024 | Feb 5, 2024 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 109,500 | — | — | 1,495,103 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 437,800 | — | — | 437,800 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 82,200 | — | — | 1,385,603 | Feb 1, 2023 | Feb 3, 2023 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 328,700 | — | — | 328,700 | Feb 1, 2023 | Feb 3, 2023 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 285,000 | $2.81 | $800.9K | 285,000 | Jan 20, 2022 | Jan 20, 2022 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | SALE Chief Scientific Officer | 200,000 | $5.09 | $1.02M | 1,303,403 | Dec 1, 2021 | Dec 3, 2021 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 290,000 | — | — | 290,000 | Feb 13, 2021 | Feb 17, 2021 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Feb 17, 2020 | Feb 19, 2020 ↗ | View → |